Want to see TSE:LEXT full AI Analyst Report?
Top Page
Lexston Life Sciences Corp.
(LEXT)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.06
▼(-22.50% Downside)
Action:Reiterated
Date:09/19/26
The score is held down primarily by very weak financial performance (minimal/zero revenue, persistent losses, and ongoing cash burn). Technical indicators also point to continued downside/weak momentum (price below major moving averages and negative MACD). Valuation offers limited support because the negative P/E reflects losses and there is no dividend yield.
Positive Factors
Zero reported debt
The absence of reported debt reduces solvency and interest-burden risk, giving the company a cleaner capital structure than a similarly loss-making business with leverage. This preserves some financial flexibility if operations improve or new funding is required.
Negative Factors
No established revenue base
The absence of reported revenue means the company lacks evidence of an established commercial engine, recurring customer demand, or operating scale. Without a revenue base, future performance depends heavily on successfully converting planned activity into sales over the coming periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Zero reported debt
The absence of reported debt reduces solvency and interest-burden risk, giving the company a cleaner capital structure than a similarly loss-making business with leverage. This preserves some financial flexibility if operations improve or new funding is required.
Read all positive factors
Lexston Life Sciences Corp. (LEXT) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$1.56M
Dividend YieldN/A
Average Volume (3M)23.76K
Price to Earnings (P/E)―
Beta (1Y)0.11
Revenue GrowthN/A
EPS Growth70.20%
CountryCA
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)-0.09
Shares Outstanding25,988,218
10 Day Avg. Volume16,852
30 Day Avg. Volume23,762
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.99
Price to Sales (P/S)0.00
P/FCF Ratio-0.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lexston Life Sciences Corp. Business Overview & Revenue Model
Company Description
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. The company holds a 100% interest in the Dory property located in the west of Port Alberni of British Columbia; and holds agreement of 100% inte...
Lexston Life Sciences Corp. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
48
Neutral
Cash Flow
14
Very Negative
| Breakdown | May 2026 | Aug 2025 | Aug 2024 | May 2023 | Aug 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 361.01K |
| Gross Profit | 0.00 | 0.00 | -26.39K | -29.80K | 241.49K |
| EBITDA | -1.35M | -1.54M | -648.32K | -841.73K | -2.29M |
| Net Income | -1.42M | -1.62M | -867.71K | -1.11M | -2.32M |
Balance Sheet | |||||
| Total Assets | 891.25K | 279.49K | 750.95K | 814.30K | 952.80K |
| Cash, Cash Equivalents and Short-Term Investments | 126.52K | 2.32K | 390.40K | 511.00K | 590.49K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 149.23K | 208.82K | 39.87K | 11.21K | 79.09K |
| Stockholders Equity | 742.02K | 70.67K | 711.08K | 803.10K | 873.71K |
Cash Flow | |||||
| Free Cash Flow | -1.10M | -1.19M | -723.16K | -987.74K | -1.40M |
| Operating Cash Flow | -1.10M | -1.19M | -523.18K | -987.74K | -1.40M |
| Investing Cash Flow | -61.26K | -10.00K | -199.99K | 0.00 | -109.97K |
| Financing Cash Flow | 1.29M | 814.66K | 602.57K | 908.24K | 1.15M |
Lexston Life Sciences Corp. Technical Analysis
Negative
0.08
Price Trends
0.08
Negative
0.07
Negative
0.08
Negative
Market Momentum
>-0.01
Negative
39.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEXT, the sentiment is Negative. The current price of 0.08 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.08, and above the 200-day MA of 0.08, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 39.33 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LEXT.
Lexston Life Sciences Corp. Peers Comparison
UnderperformOutperform
Sector (61)
TSE:LEXT
Lexston Life Sciences Corp.
0.06
-0.13
-70.27%
TSE:LSD.H
Lightspeed Discoveries
0.05
0.02
42.86%
TSE:LCR
NeonMind Biosciences Inc
0.02
-0.02
-50.00%
Lexston Life Sciences Corp. Corporate Events
Business Operations and StrategyShareholder Meetings
Lexston Mining Shareholders Back Board, Auditor and Stock Option Plan at AGM
Positive
Sep 16, 2026
Lexston Mining Corporation reported that shareholders approved all matters at its annual general and special meeting held on September 15, 2026. Investors confirmed the board size at four directors, re-elected Jagdip Bal, Jatinder J. Manhas, Clint...
Business Operations and StrategyExecutive/Board Changes
Lexston Mining Grants Stock Options to Align Stakeholder Interests
Positive
Aug 22, 2026
Lexston Mining Corporation has granted incentive stock options to directors, officers and consultants to purchase up to 650,000 common shares at an exercise price of $0.08 per share for a period of five years. The options and any shares issued upo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.